DNA Synthesis Market Report 2026

DNA Synthesis Market Overview

• DNA Synthesis market size has reached to $5.18 billion in 2025 • Expected to grow to $13.06 billion in 2030 at a compound annual growth rate (CAGR) of 20.2% • Growth Driver: Increasing Demand For Personalized Medicine Fueling The Growth Of The Market Due To Rising Adoption Of Precision Healthcare Solutions • Market Trend: Next-Generation Technology Enables Creation Of Complex Genetic Constructs • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under DNA Synthesis Market?

DNA synthesis refers to the natural or artificial process of creating a new strand of deoxyribonucleic acid. It occurs naturally during cell division when the DNA replicates to pass genetic information to daughter cells. In biotechnology, DNA synthesis can also mean the chemical production of custom DNA sequences in a lab. The main service types of DNA synthesis include oligonucleotide synthesis, standard oligonucleotide synthesis, custom oligonucleotide synthesis, gene synthesis, custom gene synthesis, and gene library synthesis. Oligonucleotide synthesis is the chemical process of creating short sequences of nucleotides (oligonucleotides) used in genetic testing, research, diagnostics, and therapeutics. There are various methods such as solid-phase synthesis, PCR-based enzyme synthesis, and chip-based synthesis. These are used in different applications, including research and development, diagnostics, therapeutics, synthetic biology, and others. The key end users are pharmaceutical and biotechnology companies, contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs), academic and research institutes, and others.

What Is The DNA Synthesis Market Growth Forecast?

The dna synthesis market size is expected to see exponential growth in the next few years. It will grow to $13.06 billion in 2030 at a compound annual growth rate (CAGR) of 20.2%. The growth in the forecast period can be attributed to technological advancements in automated dna synthesis platforms, rising applications in synthetic biology and gene therapy, expansion of cros and cdmos, increasing regulatory compliance and quality standards, integration of ai and bioinformatics in dna sequence design. Major trends in the forecast period include rising demand for custom dna sequences, growth in synthetic biology applications, increasing use of gene libraries for research, expansion of pcr-based and chip-based synthesis methods, focus on high-purity and accurate oligonucleotide production.

What Is The Driver Of The DNA Synthesis Market?

The increasing demand for personalized medicine is expected to propel the growth of the DNA synthesis market going forward. Personalized medicine refers to a medical approach that tailors treatment and prevention strategies to individual genetic profiles, lifestyles, and environments to achieve optimal therapeutic outcomes. The demand for personalized medicine is rising primarily due to advancements in genomic technologies, which enable treatments tailored to an individual’s genetic profile, improving efficacy and reducing side effects. DNA synthesis supports personalized medicine by enabling the creation of custom DNA sequences used in gene editing, diagnostic tools, and precision therapeutics, thereby facilitating more accurate, efficient, and individualized healthcare solutions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based advocacy company, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from 6 in 2022. Therefore, the increasing demand for personalized medicine is driving the DNA synthesis industry.

Key Players In The Global DNA Synthesis Market

Major companies operating in the dna synthesis market are GenScript Biotech Corporation, Twist Bioscience Corporation, Bioneer Corporation, DNA Script, Eton Bioscience, LGC Biosearch Technologies, Ansa Biotechnologies, Synbio Technologies, Quintara Biosciences, Elegen Corporation, Biomatik Corporation, Bio Basic Inc., Evonetix Ltd.

Global DNA Synthesis Market Trends and Insights

Major companies operating in the DNA synthesis market are focusing on developing innovative solutions, such as synthetic deoxyribonucleic acid molecules, to enable faster, more accurate, and cost-effective development of gene therapies, diagnostics, and synthetic biology applications. Synthetic DNA molecules are artificially constructed sequences of nucleotides designed in the lab to mimic or modify natural deoxyribonucleic acid for use in research, diagnostics, and biotechnology applications. For instance, in May 2025, Ribbon Biolabs, an Austria-based synthetic biology company, launched MiroSynth, a novel class of complex synthetic DNA molecules. It is designed to enable high-throughput, automated, and scalable production of long and complex deoxyribonucleic acid sequences for advanced biotechnological applications. It offers unique features such as enhanced accuracy in sequence assembly, extended strand length capability, and rapid construction of intricate genetic constructs, making it ideal for research, therapeutic development, and industrial biotech. Its flexible design allows integration into diverse workflows, empowering researchers and developers to accelerate innovation in genomics, synthetic biology, and personalized medicine.

What Are Latest Mergers And Acquisitions In The DNA Synthesis Market?

In February 2025, Maravai LifeSciences, a US-based life sciences company, acquired the DNA and RNA business of Officinae Bio for an undisclosed amount. The acquisition aims to strengthen Maravai’s position in the nucleic acid production market by expanding its capabilities in high-quality DNA and RNA synthesis. Officinae Bio is an Italy-based biotechnology company that specializes in the development and manufacturing of DNA and RNA for research and therapeutic applications.

What Defines the DNA Synthesis Market?

The DNA synthesis market consists of revenues earned by entities by creating synthetic DNA sequences for use in research, diagnostics, therapeutics, and biotechnology applications. The market value includes the value of related goods sold by the service provider or included within the service offering. The DNA synthesis market includes sales of custom DNA oligonucleotides, gene synthesis kits, reagents, and associated synthesis tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the DNA Synthesis Market Report 2026?

The dna synthesis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the dna synthesis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.